ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis

ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis

Cell-free circulating tumor DNA (ctDNA) is synthesized by tumor cells, including metastatic tumors, and circulates in the bloodstream. Evidence suggests that ctDNA is a potential predictive and prognostic biomarker for colorectal cancer (CRC), but its predictive efficacy in detecting CRC liver metas...

Full description

Bibliographic Details
Main Authors: Wang Da, Zhao Penglai, Lu Tingting, Ren Jingyao, Zhu Lihui, Han Xiaoyong, Zhang Guangming, Dong Xiaohua, Ma Haizhong, Yu Miao, Cai Hui
Format: Article
Language:English
Published: De Gruyter 2023-05-01
Series:Open Life Sciences
Subjects:
ctdna
colorectal cancer liver metastasis
meta-analysis
prognostic biomarker
Online Access:https://doi.org/10.1515/biol-2022-0615

Internet

https://doi.org/10.1515/biol-2022-0615

Similar Items